Следене
Ahmed M. Soliman, MS, PhD
Ahmed M. Soliman, MS, PhD
Director, Health Economics and Outcomes Research, AbbVie Inc.
Потвърден имейл адрес: abbvie.com
Заглавие
Позовавания
Позовавания
Година
Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women
MJ Fuldeore, AM Soliman
Gynecologic and obstetric investigation 82 (5), 453-461, 2017
2822017
The direct and indirect costs associated with endometriosis: a systematic literature review
AM Soliman, H Yang, EX Du, C Kelley, C Winkel
Human reproduction 31 (4), 712-722, 2016
2242016
Elagolix for heavy menstrual bleeding in women with uterine fibroids
WD Schlaff, RT Ackerman, A Al-Hendy, DF Archer, KT Barnhart, ...
New England Journal of Medicine 382 (4), 328-340, 2020
1722020
The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study
AM Soliman, KS Coyne, E Zaiser, J Castelli-Haley, MJ Fuldeore
Journal of Psychosomatic Obstetrics & Gynecology 38 (4), 238-248, 2017
1562017
The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace and at home
AM Soliman, KS Coyne, KS Gries, J Castelli-Haley, MC Snabes, ...
Journal of managed care & specialty pharmacy 23 (7), 745-754, 2017
1472017
Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States
AM Soliman, E Surrey, M Bonafede, JK Nelson, J Castelli-Haley
Advances in therapy 35, 408-423, 2018
1382018
Factors associated with time to endometriosis diagnosis in the United States
AM Soliman, M Fuldeore, MC Snabes
Journal of women's health 26 (7), 788-797, 2017
1352017
Impact of endometriosis on life-course potential: a narrative review
SA Missmer, FF Tu, SK Agarwal, C Chapron, AM Soliman, S Chiuve, ...
International Journal of General Medicine, 9-25, 2021
1262021
Long-term outcomes of elagolix in women with endometriosis: results from two extension studies
E Surrey, HS Taylor, L Giudice, BA Lessey, MS Abrao, DF Archer, ...
Obstetrics & Gynecology 132 (1), 147-160, 2018
1192018
The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013
AM Soliman, H Yang, EX Du, SS Kelkar, C Winkel
American journal of obstetrics and gynecology 213 (2), 141-160, 2015
1172015
Impact of endometriosis diagnostic delays on healthcare resource utilization and costs
E Surrey, AM Soliman, H Trenz, C Blauer-Peterson, A Sluis
Advances in therapy 37, 1087-1099, 2020
1052020
Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases
M Fuldeore, H Yang, EX Du, AM Soliman, EQ Wu, C Winkel
Fertility and sterility 103 (1), 163-171, 2015
972015
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial
LE Kristensen, M Keiserman, K Papp, L McCasland, D White, W Lu, ...
Annals of the Rheumatic Diseases 81 (2), 225-231, 2022
922022
Risk of developing comorbidities among women with endometriosis: a retrospective matched cohort study
ES Surrey, AM Soliman, SJ Johnson, M Davis, J Castelli-Haley, ...
Journal of women's health 27 (9), 1114-1123, 2018
892018
Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study
DF Archer, EA Stewart, RI Jain, RA Feldman, AS Lukes, JD North, ...
Fertility and sterility 108 (1), 152-160. e4, 2017
872017
Prevalence, symptomatic burden, and diagnosis of endometriosis in Canada: cross-sectional survey of 30 000 women
S Singh, AM Soliman, Y Rahal, C Robert, I Defoy, P Nisbet, N Leyland
Journal of Obstetrics and Gynaecology Canada 42 (7), 829-838, 2020
762020
Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey
AM Soliman, MK Margolis, J Castelli-Haley, MJ Fuldeore, CD Owens, ...
Current medical research and opinion 33 (11), 1971-1978, 2017
682017
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
A Östör, F Van den Bosch, K Papp, C Asnal, R Blanco, J Aelion, ...
Annals of the Rheumatic Diseases 81 (3), 351-358, 2022
672022
Optimal Diabetes Care Outcomes Following Face-to-Face Medication Therapy Management Services
AR Brummel, AM Soliman, AM Carlson, DR Oliveira
Population Health Management 16 (1), 28-34, 2013
662013
Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis
MJ Fuldeore, AM Soliman
International journal of women's health, 403-411, 2017
652017
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20